Beam Therapeutics (BEAM) News Today → Shocking: One AI startup's revenue could surge 4,735% (From Manward Press) (Ad) Free BEAM Stock Alerts $24.62 +0.83 (+3.49%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 4:26 AM | americanbankingnews.comBeam Therapeutics Inc. (NASDAQ:BEAM) Short Interest Up 6.5% in AprilMay 17 at 8:59 PM | marketbeat.comBeam Therapeutics Inc. (NASDAQ:BEAM) Shares Acquired by Nikko Asset Management Americas Inc.Nikko Asset Management Americas Inc. boosted its holdings in Beam Therapeutics Inc. (NASDAQ:BEAM - Free Report) by 43.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,358,091 shares of the company's stock after purchasing aMay 14, 2024 | globenewswire.comBeam Therapeutics to Present Data Highlighting Robust Manufacturing Process for BEAM-101 at 2024 European Hematology Association (EHA) Hybrid CongressMay 14, 2024 | americanbankingnews.comBeam Therapeutics Inc. (NASDAQ:BEAM) Receives Average Recommendation of "Hold" from BrokeragesMay 13, 2024 | marketbeat.comBeam Therapeutics (NASDAQ:BEAM) Trading Up 10.1%Beam Therapeutics (NASDAQ:BEAM) Shares Up 10.1%May 13, 2024 | msn.comWirral patient first to access laser beam surgery to prevent epileptic seizuresMay 13, 2024 | marketbeat.comInternational Assets Investment Management LLC Purchases Shares of 68,050 Beam Therapeutics Inc. (NASDAQ:BEAM)International Assets Investment Management LLC acquired a new stake in Beam Therapeutics Inc. (NASDAQ:BEAM - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 68,050 shares of the company's stock, valuedMay 13, 2024 | americanbankingnews.comBrokers Issue Forecasts for Beam Therapeutics Inc.'s FY2024 Earnings (NASDAQ:BEAM)May 12, 2024 | msn.comLancashire NHS patients to access world-leading laser beam surgery to prevent epileptic seizuresMay 11, 2024 | americanbankingnews.comBeam Therapeutics Inc. (NASDAQ:BEAM) Forecasted to Earn Q2 2024 Earnings of ($1.10) Per ShareMay 11, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Beam Therapeutics (BEAM), Cormedix (CRMD) and Applied Therapeutics (APLT)May 10, 2024 | marketbeat.comBeam Therapeutics Inc. (NASDAQ:BEAM) to Post Q2 2024 Earnings of ($1.10) Per Share, Wedbush ForecastsBeam Therapeutics Inc. (NASDAQ:BEAM - Free Report) - Investment analysts at Wedbush raised their Q2 2024 earnings per share estimates for shares of Beam Therapeutics in a research note issued to investors on Tuesday, May 7th. Wedbush analyst D. Nierengarten now forecasts that the company will posMay 10, 2024 | americanbankingnews.comBarclays Lowers Beam Therapeutics (NASDAQ:BEAM) Price Target to $33.00May 10, 2024 | americanbankingnews.comBeam Therapeutics Inc. to Post Q3 2024 Earnings of ($1.23) Per Share, Leerink Partnrs Forecasts (NASDAQ:BEAM)May 10, 2024 | americanbankingnews.comWilliam Blair Weighs in on Beam Therapeutics Inc.'s Q2 2024 Earnings (NASDAQ:BEAM)May 9, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (ACAD), Beam Therapeutics (BEAM) and Mirum Pharmaceuticals (MIRM)May 9, 2024 | finance.yahoo.comBeam Therapeutics Inc. (NASDAQ:BEAM) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?May 9, 2024 | marketbeat.comLeerink Partnrs Comments on Beam Therapeutics Inc.'s Q3 2024 Earnings (NASDAQ:BEAM)Beam Therapeutics Inc. (NASDAQ:BEAM - Free Report) - Stock analysts at Leerink Partnrs upped their Q3 2024 earnings estimates for shares of Beam Therapeutics in a research note issued to investors on Tuesday, May 7th. Leerink Partnrs analyst M. Foroohar now expects that the company will post earnMay 9, 2024 | investorplace.comBiotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing MedicineMay 8, 2024 | marketbeat.comBeam Therapeutics (NASDAQ:BEAM) Price Target Lowered to $33.00 at BarclaysBarclays dropped their price target on Beam Therapeutics from $42.00 to $33.00 and set an "equal weight" rating on the stock in a research report on Wednesday.May 8, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Beam Therapeutics (BEAM), Travere Therapeutics (TVTX) and Oscar Health (OSCR)May 8, 2024 | marketbeat.comBeam Therapeutics (NASDAQ:BEAM) Releases Earnings Results, Beats Estimates By $0.21 EPSBeam Therapeutics (NASDAQ:BEAM - Get Free Report) released its earnings results on Tuesday. The company reported ($1.21) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($1.42) by $0.21. Beam Therapeutics had a negative net margin of 35.09% and a negative return on equity of 15.90%. The company had revenue of $7.40 million for the quarter, compared to the consensus estimate of $17.09 million. During the same period in the prior year, the company posted ($1.33) EPS. The company's revenue was down 69.4% compared to the same quarter last year.May 8, 2024 | globenewswire.comBeam Therapeutics to Participate in RBC Capital Markets 2024 Global Healthcare ConferenceMay 7, 2024 | finance.yahoo.comBeam Therapeutics Inc (BEAM) Reports Q1 2024 Earnings: A Detailed OverviewMay 7, 2024 | marketbeat.comBeam Therapeutics (NASDAQ:BEAM) Rating Reiterated by WedbushWedbush reissued an "outperform" rating and set a $57.00 target price on shares of Beam Therapeutics in a research note on Tuesday.May 7, 2024 | investorplace.comBEAM Stock Earnings: Beam Therapeutics Beats EPS, Misses Revenue for Q1 2024May 7, 2024 | globenewswire.comBeam Therapeutics Reports Pipeline Updates and First Quarter 2024 Financial ResultsMay 6, 2024 | msn.comEpilepsy patients to be offered ‘game-changing’ laser therapy in NHS rolloutMay 5, 2024 | marketbeat.comVestmark Advisory Solutions Inc. Makes New Investment in Beam Therapeutics Inc. (NASDAQ:BEAM)Vestmark Advisory Solutions Inc. bought a new stake in shares of Beam Therapeutics Inc. (NASDAQ:BEAM - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 98,215 shares of the company's stock, valued at approximatelyMay 2, 2024 | theglobeandmail.comThe best and worst recent ETF performers and the stock trends they revealMay 2, 2024 | finance.yahoo.comIBA signs contract with Yale New Haven Health and Hartford HealthCare to install Proteus®ONE proton therapy solution in Connecticut, USMay 1, 2024 | yahoo.comOU researchers develop new technology to improve bridges and roadsMay 1, 2024 | msn.comThe Days of Our Lives Superstar Casting That Would Blow Things *All* the Way Up - Not Just for Jada But Salem!May 1, 2024 | finance.yahoo.comBest Theratronics workers go on strike after company's 0% offerMay 1, 2024 | msn.comBest Puzzle Games On Game PassApril 30, 2024 | dailymail.co.ukWarner Bros. lands seven-figure rights deal for Avengelyne starring Margot Robbie with Olivia Wilde set to direct the comic book adaptationApril 30, 2024 | yahoo.comWe Tested (and Rated!) All the Dining Tables at Pottery Barn — Here Are the Best to Suit Your Style and SpaceApril 30, 2024 | msn.comCervical cancer: Therapies that have transformed the treatment landscapeApril 29, 2024 | marketbeat.comBeam Therapeutics (NASDAQ:BEAM) Trading 4.7% Higher Beam Therapeutics (NASDAQ:BEAM) Trading 4.7% HigherApril 29, 2024 | sfgate.comThe best San Francisco events you missed in the last week (or so)April 29, 2024 | finance.yahoo.comParticle Therapy Market to hit USD 1.7 Bn by 2032, says Global Market Insights Inc.April 28, 2024 | yahoo.comLentigo (Liver Spots)April 28, 2024 | msn.com10 Tiny Houses Under 525 Square Feet That’ll Make You Consider Small-Space LivingApril 26, 2024 | msn.comUSFDA gives nod to Novartis’ therapy for rare cancer among childrenApril 25, 2024 | marketbeat.comBeam Therapeutics (NASDAQ:BEAM) Shares Down 6.6% Beam Therapeutics (NASDAQ:BEAM) Trading Down 6.6%April 23, 2024 | seekingalpha.comBeam Therapeutics: A 'Hold' Amid High Valuation And Uncertain Revenue ProspectsApril 23, 2024 | marketbeat.comBeam Therapeutics (NASDAQ:BEAM) Stock Rating Reaffirmed by WedbushWedbush reaffirmed an "outperform" rating and set a $57.00 price target on shares of Beam Therapeutics in a research note on Tuesday.April 22, 2024 | msn.comBeam Therapeutics Stock (NASDAQ:BEAM): Investing in Cutting-Edge Gene EditingApril 21, 2024 | marketbeat.comInternational Assets Investment Management LLC Makes New $1.85 Million Investment in Beam Therapeutics Inc. (NASDAQ:BEAM)International Assets Investment Management LLC purchased a new position in shares of Beam Therapeutics Inc. (NASDAQ:BEAM - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 68,050 shares of the company's sApril 19, 2024 | marketbeat.comBeam Therapeutics Inc. (NASDAQ:BEAM) Shares Purchased by Sumitomo Mitsui Trust Holdings Inc.Sumitomo Mitsui Trust Holdings Inc. boosted its stake in Beam Therapeutics Inc. (NASDAQ:BEAM - Free Report) by 43.6% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 2,358,091 shares of the company's stock after acquiring an additional 715,911 shares d Get Beam Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BEAM and its competitors with MarketBeat's FREE daily newsletter. Email Address Shocking: One AI startup's revenue could surge 4,735% (Ad)Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner. Click here to discover the AI chip company BEAM Media Mentions By Week BEAM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BEAM News Sentiment▼0.310.42▲Average Medical News Sentiment BEAM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BEAM Articles This Week▼126▲BEAM Articles Average Week Get Beam Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BEAM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SANA News NVAX News ADMA News DNA News FUSN News CGON News KYMR News INBX News APGE News RXRX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BEAM) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beam Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
